000281504 001__ 281504
000281504 005__ 20251102002044.0
000281504 0247_ $$2doi$$a10.1162/IMAG.a.161
000281504 0247_ $$2pmid$$apmid:40995462
000281504 0247_ $$2pmc$$apmc:PMC12455054
000281504 0247_ $$2altmetric$$aaltmetric:181645794
000281504 037__ $$aDZNE-2025-01125
000281504 041__ $$aEnglish
000281504 082__ $$a610
000281504 1001_ $$0P:(DE-2719)2811871$$aArboit, Alberto$$b0$$eFirst author$$udzne
000281504 245__ $$aAcetaminophen affects the duration but not the occurrence of BOLD signal decline in the dorsal hippocampus after induction of neuronal afterdischarges.
000281504 260__ $$aCambridge, MA$$bMIT Press$$c2025
000281504 3367_ $$2DRIVER$$aarticle
000281504 3367_ $$2DataCite$$aOutput Types/Journal article
000281504 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1761731183_30625
000281504 3367_ $$2BibTeX$$aARTICLE
000281504 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281504 3367_ $$00$$2EndNote$$aJournal Article
000281504 520__ $$aCombined in vivo electrophysiological and functional magnetic resonance imaging (fMRI) measurements were used to monitor neuronal and hemodynamic responses in the right dorsal hippocampus during and after electrical stimulation of the right perforant pathway with a short period of 20 Hz pulses. These measurements were performed under two conditions: 1.5% isoflurane (which has a long-term vasodilator effect) or 100 µg/kg medetomidine (which has a long-term vasoconstrictor effect). The stimulation elicited a short period of neuronal afterdischarges (nAD) followed by a sustained decline in fMRI BOLD signals, as previously described (Arboit et al., 2024). While the duration of nAD was similar in presence of isoflurane and medetomidine, the subsequent decline of BOLD signal was significantly longer with isoflurane than with medetomidine. However, when the same experiments were performed in the presence of acetaminophen, the duration of the sustained decline of BOLD signals became similar: acetaminophen significantly prolonged the decline in the presence of medetomidine, whereas it only slightly shortened it in the presence of isoflurane. As acetaminophen did not affect the generation and intensity of nAD, the results indicate that nAD activates at least two different neurovascular coupling (NVC) mechanisms that mediate the sustained BOLD signal decline, of which acetaminophen affects the maintenance.
000281504 536__ $$0G:(DE-HGF)POF4-351$$a351 - Brain Function (POF4-351)$$cPOF4-351$$fPOF IV$$x0
000281504 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281504 650_7 $$2Other$$aBOLD-fMRI
000281504 650_7 $$2Other$$adentate gyrus
000281504 650_7 $$2Other$$ain vivo electrophysiology
000281504 650_7 $$2Other$$anegative BOLD response
000281504 650_7 $$2Other$$aneurovascular coupling
000281504 7001_ $$0P:(DE-2719)2278716$$aKrautwald, Karla$$b1$$udzne
000281504 7001_ $$0P:(DE-2719)2810456$$aAngenstein, Frank$$b2$$eLast author$$udzne
000281504 773__ $$0PERI:(DE-600)3167925-0$$a10.1162/IMAG.a.161$$gVol. 3, p. IMAG.a.161$$pIMAG.a.161$$tImaging neuroscience$$v3$$x2837-6056$$y2025
000281504 8564_ $$uhttps://pub.dzne.de/record/281504/files/DZNE-2025-01125%20SUP.pdf
000281504 8564_ $$uhttps://pub.dzne.de/record/281504/files/DZNE-2025-01125.pdf$$yOpenAccess
000281504 8564_ $$uhttps://pub.dzne.de/record/281504/files/DZNE-2025-01125.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281504 8564_ $$uhttps://pub.dzne.de/record/281504/files/DZNE-2025-01125%20SUP.pdf?subformat=pdfa$$xpdfa
000281504 909CO $$ooai:pub.dzne.de:281504$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000281504 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811871$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000281504 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2278716$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000281504 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810456$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000281504 9131_ $$0G:(DE-HGF)POF4-351$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vBrain Function$$x0
000281504 9141_ $$y2025
000281504 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000281504 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-09-26T09:40:26Z
000281504 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-09-26T09:40:26Z
000281504 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281504 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-09-26T09:40:26Z
000281504 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-01-02
000281504 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000281504 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-01-02
000281504 9201_ $$0I:(DE-2719)1310004$$kAG Angenstein$$lFunctional Neuroimaging$$x0
000281504 980__ $$ajournal
000281504 980__ $$aVDB
000281504 980__ $$aUNRESTRICTED
000281504 980__ $$aI:(DE-2719)1310004
000281504 9801_ $$aFullTexts